Metraipolis › archive › dc_5116e04467e5

Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models — Europe PMC PMID:40858106

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40858106
DOI
10.1016/j.xcrm.2025.102313
License (as archived)
solo-consultazione
Archived
2026-11-10T08:39:54.432Z
SHA-256 of the archived text
341771ac2d9522d01333b2fe23ae201dbcc8c859cba04fc5845f58266676185c
Stable URL of this page
https://metraipolis.com/documento/dc_5116e04467e5

How to cite

Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models — Europe PMC PMID:40858106 — Europe PMC (en), https://europepmc.org/article/MED/40858106 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5116e04467e5 (Metraipolis archive dc_5116e04467e5, sha256 341771ac2d9522d01333b2fe23ae201dbcc8c859cba04fc5845f58266676185c)
BibTeX
@misc{dc5116e04467e5,
  title = {Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models — Europe PMC PMID:40858106},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40858106},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5116e04467e5; sha256 341771ac2d9522d01333b2fe23ae201dbcc8c859cba04fc5845f58266676185c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40858106. Agents can read the archived copy with the MCP tool read_document.